The guide 2011/24 / EU on patients’ rights in cross-border healthcare sets out the conditions under which the patient can travel abroad (in another EU country) to receive medical treatment and reimbursement of the costs. It covers health care costs, as well as the prescription and distribution of medicines and medical devices.
Patients enjoy more rights and choices within Cross-border Healthcare since they can, within the defined national regulations (listed below), seek medical treatment in another Member State and the costs are reimbursed, the amount estimated to be due if they had receive the care in their own country.
- Patients who have received treatment in another Member State have remote access or have at least one copy of their medical records
- If medical surveillance proves necessary, the same medical follow-up is provided as would be provided if such health care was provided to Cyprus
- Recipes issued in another Member State of the European Union are recognized in the country of residence of the patient (ie Cyprus) and vice versa. Patients can receive a prescription from any Member State if they have been approved for sale and are available in the Member State that they wish to obtain, even if not available in their own country
In cases where pharmaceuticals are not offered in the state formulary, patients may use the Registered Medicines Commission, which is the competent authority for assessing Registered Queries Drug Administration.